Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases. It
targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts …

PURPOSE: Studies on mortality associated with systemic sclerosis have been limited by
small sample sizes. We aimed to obtain large-scale evidence on survival outcomes and …

Objective To estimate the prevalence, incidence, survival, and disease characteristics of
systemic sclerosis (SSc) in the Detroit tricounty area. Methods A census of SSc cases for the …

Covering both the scientific basis of rheumatology and practical, clinical information for
rheumatologists and trainees, Rheumatology, 8th Edition, remains a leading text in this fast …

Scleroderma (systemic sclerosis) is associated with several autoantibodies, each of which is
useful in the diagnosis of affected patients and in determining their prognosis. Anti …

Objective To clarify the association of clinical and prognostic features with dermatomyositis
(DM)-specific autoantibodies (Abs) in adult Japanese patients with DM. Design …

Systemic sclerosis (SSc), also known as scleroderma, is a rare connective tissue disease
characterized by vascular and immune dysfunction, leading to fibrosis that can damage …

The purpose of this study was to determine the cumulative incidence of lupus nephritis (LN)
and the factors predictive of its occurrencein a multiethnic systemic lupus erythematosus …

Autoantibodies directed against a variety of nuclear, cytoplasmic and extracellular
autoantigens are a serological hallmark of systemic sclerosis. This review provides an …

Objective To determine the frequency with which scleroderma (systemic sclerosis; SSc)
recurs in families and the familial relative risk (λ) in the US. Methods Family histories of SSc …